Covered recipient · General Payments record
JOE WALTER TERRY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,708.54
- Reported across 310 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $579.46 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $153.86 | 3 |
| ABBVIE INC. | $140.19 | 9 |
| PFIZER INC. | $98.07 | 5 |
| Amgen Inc. | $47.95 | 3 |
| Acerta Pharma LLC | $34.70 | 2 |
| Lilly USA, LLC | $27.03 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.56 | 1 |
| Inari Medical, Inc. | $20.41 | 1 |
| Exact Sciences Corporation | $16.41 | 1 |
| Abbott Laboratories | $15.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.28 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125034177 | CMS |
| ABBVIE INC. | $6.40 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211560 | CMS |
| ABBVIE INC. | $12.92 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211562 | CMS |
| ABBVIE INC. | $13.04 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211564 | CMS |
| ABBVIE INC. | $23.62 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211566 | CMS |
| ABBVIE INC. | $16.03 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211568 | CMS |
| ABBVIE INC. | $18.89 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211570 | CMS |
| ABBVIE INC. | $18.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211572 | CMS |
| ABBVIE INC. | $13.38 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211574 | CMS |
| ABBVIE INC. | $17.79 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106211576 | CMS |
| Amgen Inc. | $17.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397364 | CMS |
| Amgen Inc. | $13.87 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397360 | CMS |
| Amgen Inc. | $16.96 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397362 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105876385 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.75 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104211757 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.56 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117985040 | CMS |
| Exact Sciences Corporation | $16.41 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114929807 | CMS |
| GlaxoSmithKline, LLC. | $15.53 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116027463 | CMS |
| GlaxoSmithKline, LLC. | $15.18 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116562858 | CMS |
| GlaxoSmithKline, LLC. | $123.15 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116569447 | CMS |
| Inari Medical, Inc. | $20.41 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140169890 | CMS |
| Lilly USA, LLC | $13.49 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065699 | CMS |
| Lilly USA, LLC | $13.54 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135068437 | CMS |
| PFIZER INC. | $18.02 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132042301 | CMS |
| PFIZER INC. | $17.96 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132041701 | CMS |
| PFIZER INC. | $20.37 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132054090 | CMS |
| PFIZER INC. | $19.49 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132069725 | CMS |
| PFIZER INC. | $22.23 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132068755 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.